Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy
Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superior...
Gespeichert in:
Veröffentlicht in: | ACS applied materials & interfaces 2022-02, Vol.14 (4), p.4914-4920 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4920 |
---|---|
container_issue | 4 |
container_start_page | 4914 |
container_title | ACS applied materials & interfaces |
container_volume | 14 |
creator | Song, Yan Sun, Yuan Tang, Minglu Yue, Zhengya Ni, Jiatong Zhao, Junge Wang, Wenxin Sun, Tiedong Shi, Lianxu Wang, Lei |
description | Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy. |
doi_str_mv | 10.1021/acsami.1c19985 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2622278957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622278957</sourcerecordid><originalsourceid>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</originalsourceid><addsrcrecordid>eNp1kM9PwjAUxxujEUSvHk2PxmTQdi1bj4aAkGA0Bi9elq57C8NtHe1Q519vDcjNvMP7kc_75r0vQteUDClhdKS0U1UxpJpKGYsT1KeS8yBmgp0ea8576MK5DSHjkBFxjnqhID4i2UfbZ1N25stU0KpStYAfTVbkBWQ47fAbmLLws0VVZOrblIBnVlXwaew7zo3F7RpwMw9ewDWmdsUH4GkJurUm62p_lR5N1lD9NXi1Bqua7hKd5ap0cHXIA_Q6m64m82D59LCY3C8DFYakDSKhgaeEaJ5yCpJkAD5xHYeZyAVnWkaMSyUjKtNIKUFFRHIItVZjkeZjFQ7Q7V63sWa7A9cmVeE0lKWqwexcwsaMsSiWIvLocI9qa5yzkCeNLSplu4SS5NfmZG9zcrDZL9wctHdpBdkR__PVA3d7wC8mG7OztX_1P7UfobKKLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622278957</pqid></control><display><type>article</type><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</creator><creatorcontrib>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</creatorcontrib><description>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</description><identifier>ISSN: 1944-8244</identifier><identifier>EISSN: 1944-8252</identifier><identifier>DOI: 10.1021/acsami.1c19985</identifier><identifier>PMID: 35050579</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Anions - chemistry ; Anions - pharmacology ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biocompatible Materials - chemical synthesis ; Biocompatible Materials - chemistry ; Biocompatible Materials - pharmacology ; Biological and Medical Applications of Materials and Interfaces ; Cell Proliferation - drug effects ; Combined Modality Therapy ; Drug Screening Assays, Antitumor ; Female ; HeLa Cells ; Humans ; Hydrogen-Ion Concentration ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Materials Testing ; Mice ; Mice, Inbred BALB C ; Neoplasms, Experimental - drug therapy ; Neoplasms, Experimental - metabolism ; Neoplasms, Experimental - pathology ; Particle Size ; Polyelectrolytes - chemistry ; Polyelectrolytes - pharmacology ; Reactive Oxygen Species - metabolism ; Surface Properties ; Tumor Microenvironment - drug effects ; Zeolites - chemistry ; Zeolites - pharmacology</subject><ispartof>ACS applied materials & interfaces, 2022-02, Vol.14 (4), p.4914-4920</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</citedby><cites>FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</cites><orcidid>0000-0002-9522-3623 ; 0000-0002-7004-9235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsami.1c19985$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsami.1c19985$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35050579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Yan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Tang, Minglu</creatorcontrib><creatorcontrib>Yue, Zhengya</creatorcontrib><creatorcontrib>Ni, Jiatong</creatorcontrib><creatorcontrib>Zhao, Junge</creatorcontrib><creatorcontrib>Wang, Wenxin</creatorcontrib><creatorcontrib>Sun, Tiedong</creatorcontrib><creatorcontrib>Shi, Lianxu</creatorcontrib><creatorcontrib>Wang, Lei</creatorcontrib><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><title>ACS applied materials & interfaces</title><addtitle>ACS Appl. Mater. Interfaces</addtitle><description>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</description><subject>Animals</subject><subject>Anions - chemistry</subject><subject>Anions - pharmacology</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biocompatible Materials - chemical synthesis</subject><subject>Biocompatible Materials - chemistry</subject><subject>Biocompatible Materials - pharmacology</subject><subject>Biological and Medical Applications of Materials and Interfaces</subject><subject>Cell Proliferation - drug effects</subject><subject>Combined Modality Therapy</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Female</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - pharmacology</subject><subject>Materials Testing</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Neoplasms, Experimental - metabolism</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Particle Size</subject><subject>Polyelectrolytes - chemistry</subject><subject>Polyelectrolytes - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Surface Properties</subject><subject>Tumor Microenvironment - drug effects</subject><subject>Zeolites - chemistry</subject><subject>Zeolites - pharmacology</subject><issn>1944-8244</issn><issn>1944-8252</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9PwjAUxxujEUSvHk2PxmTQdi1bj4aAkGA0Bi9elq57C8NtHe1Q519vDcjNvMP7kc_75r0vQteUDClhdKS0U1UxpJpKGYsT1KeS8yBmgp0ea8576MK5DSHjkBFxjnqhID4i2UfbZ1N25stU0KpStYAfTVbkBWQ47fAbmLLws0VVZOrblIBnVlXwaew7zo3F7RpwMw9ewDWmdsUH4GkJurUm62p_lR5N1lD9NXi1Bqua7hKd5ap0cHXIA_Q6m64m82D59LCY3C8DFYakDSKhgaeEaJ5yCpJkAD5xHYeZyAVnWkaMSyUjKtNIKUFFRHIItVZjkeZjFQ7Q7V63sWa7A9cmVeE0lKWqwexcwsaMsSiWIvLocI9qa5yzkCeNLSplu4SS5NfmZG9zcrDZL9wctHdpBdkR__PVA3d7wC8mG7OztX_1P7UfobKKLg</recordid><startdate>20220202</startdate><enddate>20220202</enddate><creator>Song, Yan</creator><creator>Sun, Yuan</creator><creator>Tang, Minglu</creator><creator>Yue, Zhengya</creator><creator>Ni, Jiatong</creator><creator>Zhao, Junge</creator><creator>Wang, Wenxin</creator><creator>Sun, Tiedong</creator><creator>Shi, Lianxu</creator><creator>Wang, Lei</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9522-3623</orcidid><orcidid>https://orcid.org/0000-0002-7004-9235</orcidid></search><sort><creationdate>20220202</creationdate><title>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</title><author>Song, Yan ; Sun, Yuan ; Tang, Minglu ; Yue, Zhengya ; Ni, Jiatong ; Zhao, Junge ; Wang, Wenxin ; Sun, Tiedong ; Shi, Lianxu ; Wang, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a330t-75ce4b00c4b41e90dee1e94c83d5f542c97249a9719b7aa51570fe3cca65bf6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Anions - chemistry</topic><topic>Anions - pharmacology</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biocompatible Materials - chemical synthesis</topic><topic>Biocompatible Materials - chemistry</topic><topic>Biocompatible Materials - pharmacology</topic><topic>Biological and Medical Applications of Materials and Interfaces</topic><topic>Cell Proliferation - drug effects</topic><topic>Combined Modality Therapy</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Female</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - pharmacology</topic><topic>Materials Testing</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Neoplasms, Experimental - metabolism</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Particle Size</topic><topic>Polyelectrolytes - chemistry</topic><topic>Polyelectrolytes - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Surface Properties</topic><topic>Tumor Microenvironment - drug effects</topic><topic>Zeolites - chemistry</topic><topic>Zeolites - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Yan</creatorcontrib><creatorcontrib>Sun, Yuan</creatorcontrib><creatorcontrib>Tang, Minglu</creatorcontrib><creatorcontrib>Yue, Zhengya</creatorcontrib><creatorcontrib>Ni, Jiatong</creatorcontrib><creatorcontrib>Zhao, Junge</creatorcontrib><creatorcontrib>Wang, Wenxin</creatorcontrib><creatorcontrib>Sun, Tiedong</creatorcontrib><creatorcontrib>Shi, Lianxu</creatorcontrib><creatorcontrib>Wang, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS applied materials & interfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Yan</au><au>Sun, Yuan</au><au>Tang, Minglu</au><au>Yue, Zhengya</au><au>Ni, Jiatong</au><au>Zhao, Junge</au><au>Wang, Wenxin</au><au>Sun, Tiedong</au><au>Shi, Lianxu</au><au>Wang, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy</atitle><jtitle>ACS applied materials & interfaces</jtitle><addtitle>ACS Appl. Mater. Interfaces</addtitle><date>2022-02-02</date><risdate>2022</risdate><volume>14</volume><issue>4</issue><spage>4914</spage><epage>4920</epage><pages>4914-4920</pages><issn>1944-8244</issn><eissn>1944-8252</eissn><abstract>Electrodynamic therapy (EDT) and chemodynamic therapy (CDT) have the potential for future tumor treatment; however, their underlying applications are greatly hindered owing to their inherent drawbacks. The combination of EDT and CDT has been considered to be an effective way to maximize the superiorities of these two ROS-based methodologies. However, the development of novel nanomaterials with “one-for-all” functions still remains a big challenge. In this work, the polyoxometalate nanoparticles (NPs) were decorated using the zeolite imidazole framework (POM@ZIF-8) in order to integrate the EDT with CDT. The resulting POM@ZIF-8 NPs can effectively induce the generation of reactive oxygen species (ROS) via a catalytic reaction on the surface of POM NPs induced by an electric field (E). At the same time, POM@ZIF-8 NPs can catalyze the intracellular H2O2 into ROS via a Fenton-like reaction, thereby achieving the combination of EDT and CDT. Besides, since ZIF-8 is acid-responsive, it can protect normal tissues and avoid side effects. Of great note is that the cytotoxicity and the apoptosis rate of the POM@ZIF-8+E group (80%) were found to be significantly higher than that of the E group (55%). As a result, a high tumor inhibition phenomenon can be observed both in vitro and in vivo. The present study thus provides an alternative concept for combinational therapeutic modality with exceptional efficacy.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>35050579</pmid><doi>10.1021/acsami.1c19985</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-9522-3623</orcidid><orcidid>https://orcid.org/0000-0002-7004-9235</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1944-8244 |
ispartof | ACS applied materials & interfaces, 2022-02, Vol.14 (4), p.4914-4920 |
issn | 1944-8244 1944-8252 |
language | eng |
recordid | cdi_proquest_miscellaneous_2622278957 |
source | MEDLINE; American Chemical Society Journals |
subjects | Animals Anions - chemistry Anions - pharmacology Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biocompatible Materials - chemical synthesis Biocompatible Materials - chemistry Biocompatible Materials - pharmacology Biological and Medical Applications of Materials and Interfaces Cell Proliferation - drug effects Combined Modality Therapy Drug Screening Assays, Antitumor Female HeLa Cells Humans Hydrogen-Ion Concentration Imidazoles - chemistry Imidazoles - pharmacology Materials Testing Mice Mice, Inbred BALB C Neoplasms, Experimental - drug therapy Neoplasms, Experimental - metabolism Neoplasms, Experimental - pathology Particle Size Polyelectrolytes - chemistry Polyelectrolytes - pharmacology Reactive Oxygen Species - metabolism Surface Properties Tumor Microenvironment - drug effects Zeolites - chemistry Zeolites - pharmacology |
title | Polyoxometalate Modified by Zeolite Imidazole Framework for the pH-Responsive Electrodynamic/Chemodynamic Therapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A44%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polyoxometalate%20Modified%20by%20Zeolite%20Imidazole%20Framework%20for%20the%20pH-Responsive%20Electrodynamic/Chemodynamic%20Therapy&rft.jtitle=ACS%20applied%20materials%20&%20interfaces&rft.au=Song,%20Yan&rft.date=2022-02-02&rft.volume=14&rft.issue=4&rft.spage=4914&rft.epage=4920&rft.pages=4914-4920&rft.issn=1944-8244&rft.eissn=1944-8252&rft_id=info:doi/10.1021/acsami.1c19985&rft_dat=%3Cproquest_cross%3E2622278957%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622278957&rft_id=info:pmid/35050579&rfr_iscdi=true |